Hypotensive pharmaceutical composition comprising triple activator having activity for all of glucagon, glp-1, and gip receptors
US-2024024426-A1 · Jan 25, 2024 · US
This page is not indexed by search engines while we improve data quality.
Oh Euh Lim patents
Oh Euh Lim is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Oh Euh Lim |
| Total patents | 31 |
| First publication | Dec 17, 2015 |
| Latest publication | Jan 25, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Novel conjugate of immune-stimulating il-2 analog and preparation method thereof
US-2024009317-A1 · Jan 11, 2024 · US
Use of trigonal agonist having activities to all of glucagon, glp-1, and gip receptors in treatment of sequelae following respiratory infectious diseases
US-2023390362-A1 · Dec 7, 2023 · US
Pharmaceutical composition comprising glucagon/glp-1/gip triple agonist or long-acting conjugate thereof for preventing or treating lupus-related diseases
US-2023381281-A1 · Nov 30, 2023 · US
Novel triple agonist having activities on all of glucagon, glp-1, and gip receptors and use thereof
US-2023382974-A1 · Nov 30, 2023 · US
Pharmaceutical composition comprising glucagon/glp-1/gip triple agonist or long-acting conjugate thereof for preventing or treating vasculitis
US-2023381333-A1 · Nov 30, 2023 · US
Immunostimulating il-2 analogs
US-2023348550-A1 · Nov 2, 2023 · US
Therapeutic use of combination comprising triple agonistic long-acting conjugate or triple agonist
US-2023310630-A1 · Oct 5, 2023 · US
Immunostimulating IL-2 analogs
US-11746137-B2 · Sep 5, 2023 · US
Novel immunostimulating il-2 analogs
US-2023124171-A1 · Apr 20, 2023 · US
Recent patents
Latest publications not already listed above.
Therapeutic use of long-acting conjugate of triple agonist having activities to all of glucagon/glp-1/gip receptors for lung disease
US-2023118307-A1 · Apr 20, 2023 · US
Triple glucagon/glp-1/gip receptor agonist
US-2022213164-A1 · Jul 7, 2022 · US
Triple glucagon/GLP-1/GIP receptor agonist
US-11332508-B2 · May 17, 2022 · US
Novel immunosuppressive interleukin 2
US-2022025007-A1 · Jan 27, 2022 · US
Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist
US-2021188937-A1 · Jun 24, 2021 · US
Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
US-10981967-B2 · Apr 20, 2021 · US
Long-acting single-chain insulin analog and conjugate thereof
US-2020254108-A1 · Aug 13, 2020 · US
Insulin analogs and use thereof
US-10647753-B2 · May 12, 2020 · US
Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
US-10400020-B2 · Sep 3, 2019 · US
Triple glucagon/GLP-1/GIP receptor agonist
US-10370426-B2 · Aug 6, 2019 · US
Triple glucagon/glp-1/gip receptor agonist
US-2019218269-A1 · Jul 18, 2019 · US
Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist
US-2019153060-A1 · May 23, 2019 · US
Long-acting insulin and use thereof
US-10253082-B2 · Apr 9, 2019 · US
Triple glucagon/glp-1/gip receptor agonist
US-2019002520-A1 · Jan 3, 2019 · US
Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist
US-2018311315-A1 · Nov 1, 2018 · US
Insulin analogs and use thereof
US-2018282388-A1 · Oct 4, 2018 · US
Insulin analogs and use thereof
US-10017557-B2 · Jul 10, 2018 · US
Long-acting insulin and use thereof
US-2017101455-A1 · Apr 13, 2017 · US
Novel insulin analogs and use thereof
US-2017066811-A1 · Mar 9, 2017 · US
Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same
US-9394546-B2 · Jul 19, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hanmi Pharm Ind Co Ltd | 32 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/00 | 23 |
| A61K38/26 | 16 |
| A61P3/10 | 16 |
| C07K14/605 | 15 |
| A61K47/60 | 14 |